Early symptom improvement with risankizumab treatment in patients with moderately to severely active Crohn's disease: analysis from a Phase 2 study

Brian G. Feagan  1     William Sandborn  2     Geert R. D'Haens  3     Julian Panés  4     Arthur Kaser  5     Marc Ferrante  6     Edouard Louis  7     Olivier Dewit     Ursula Seidler     Kyung-Jo Kim     Kristina Kligys     Kori Wallace     Xiaomei Liao     Wan-Ju Lee     Markus F. Neurath    
1 Robarts Clinical Trials Inc.,London,Canada
2 University of California,San Diego,United States
3 AMC Amsterdam Inflammatory Bowel Disease Centre,Amsterdam,Netherlands
4 Hospital Clínic Barcelona,Barcelona,Spain
5 University of Cambridge Gastroenterology and Hepatology,Cambridge,United Kingdom
6 University Hospitals Leuven,Leuven,Belgium
7 U

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing